NCT00068510View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

therapeutic autologous dendritic cells

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00068510 - Vaccine Therapy in Treating Patients With Malignant Glioma | Biotech Hunter | Biotech Hunter